AAAAAA

   
Results: 1-25 | 26-38
Results: 1-25/38

Authors: Moukha-Chafiq, O Taha, ML Lazrek, HB Pannecouque, C Witvrouw, M De Clercq, E Barascut, JL Imbach, JL
Citation: O. Moukha-chafiq et al., Synthesis and biological activity of 4-substituted 1-[1-(2-hydroxyethoxy)methyl-1,2,3-triazol-(4&5)-ylmethyl]-1H-pyrazolo[3,4-d]pyrimidines, NUCLEOS NUC, 20(10-11), 2001, pp. 1797-1810

Authors: Moukha-Chafiq, O Taha, ML Lazrek, HB Vasseur, JJ Pannecouque, C Witvrouw, M De Clercq, E
Citation: O. Moukha-chafiq et al., Synthesis and biological evaluation of some 4-substituted 1-[1-(4-hydroxybutyl)-1,2,3-triazol-(4&5)-ylmethyl]1H-pyrazolo-[3,4-d]pyrimidines, NUCLEOS NUC, 20(10-11), 2001, pp. 1811-1821

Authors: Casimiro-Garcia, A De Clercq, E Pannecouque, C Witvrouw, M Loftus, TL Turpin, JA Buckheit, RW Fanwick, PE Cushman, M
Citation: A. Casimiro-garcia et al., Synthesis and anti-HIV activity of cosalane analogues incorporating two dichlorodisalicylmethane pharmacophore fragments, BIO MED CH, 9(11), 2001, pp. 2827-2841

Authors: Barreca, ML Chimirri, A De Luca, L Monforte, AM Monforte, P Rao, A Zappala, M Balzarini, J De Clercq, E Pannecouque, C Witvrouw, M
Citation: Ml. Barreca et al., Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV-1 agents, BIOORG MED, 11(13), 2001, pp. 1793-1796

Authors: Asres, K Bucar, F Kartnig, T Witvrouw, M Pannecouque, C De Clercq, E
Citation: K. Asres et al., Antiviral activity against human immunodeficiency virus type 1 (HIV-1) andtype 2 (HIV-2) of ethnobotanically selected ethiopian medicinal plants, PHYTOTHER R, 15(1), 2001, pp. 62-69

Authors: Selvam, P Chandramohan, M De Clercq, E Witvrouw, M Pannecouque, C
Citation: P. Selvam et al., Synthesis and anti-HIV activity of 4-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene) amino]-N(4,6-dimethyl-2-pyrimidinyl)-benzene sulfonamide and its derivatives, EUR J PH SC, 14(4), 2001, pp. 313-316

Authors: Chaouni-Benabdallah, A Galtier, C Allouchi, H Kherbeche, A Debouzy, JC Teulade, JC Chavignon, O Witvrouw, M Pannecouque, C Balzarini, J de Clercq, E Enguehard, C Gueiffier, A
Citation: A. Chaouni-benabdallah et al., Synthesis of 3-nitrosoimidazo[1,2-a]pyridine derivatives as potential antiretroviral agents, ARCH PHARM, 334(7), 2001, pp. 224-228

Authors: Van Laethem, K Witvrouw, M Pannecouque, C Van Remoortel, B Schmit, JC Esnouf, R Kleim, JP Balzarini, J Desmyter, J De Clercq, E Vandamme, AM
Citation: K. Van Laethem et al., Mutations in the non-nucleoside binding-pocket interfere with the multi-nucleoside resistance phenotype, AIDS, 15(5), 2001, pp. 553-561

Authors: Goebel, FD Hemmer, R Schmit, JC Bogner, JR de Clercq, E Witvrouw, M Pannecouque, C Valeyev, R Vandevelde, M Margery, H Tassignon, JP
Citation: Fd. Goebel et al., Phase I/II dose escalation and randomized withdrawal study with add-on azodicarbonamide in patients failing on current antiretroviral therapy, AIDS, 15(1), 2001, pp. 33-45

Authors: Kannan, A De Clercq, E Pannecouque, C Witvrouw, M Hartman, TL Turpin, JA Buckheit, RW Cushman, M
Citation: A. Kannan et al., Synthesis and anti-HIV activity of a bile acid analog of cosalane, TETRAHEDRON, 57(46), 2001, pp. 9385-9391

Authors: Pluymers, W Neamati, N Pannecouque, C Fikkert, V Marchand, C Burke, TR Pommier, Y Schols, D De Clercq, E Debyser, Z Witvrouw, M
Citation: W. Pluymers et al., Viral entry as the primary target for the anti-HIV activity of chicoric acid and its tetra-acetyl esters (vol 58, pg 641, 2000), MOLEC PHARM, 59(2), 2001, pp. 403-403

Authors: Santhosh, KC Paul, GC De Clercq, E Pannecouque, C Witvrouw, M Loftus, TL Turpin, JA Buckheit, RW Cushman, M
Citation: Kc. Santhosh et al., Correlation of anti-HIV activity with anion spacing in a series of cosalane analogues with extended polycarboxylate pharmacophores, J MED CHEM, 44(5), 2001, pp. 703-714

Authors: Vlieghe, P Bihel, F Clerc, T Pannecouque, C Witvrouw, M De Clercq, E Salles, JP Chermann, JC Kraus, JL
Citation: P. Vlieghe et al., New 3 '-azido-3 '-deoxythymidin-5 '-yl O-(omega-hydroxyalkyl) carbonate prodrugs: Synthesis and anti-HIV evaluation, J MED CHEM, 44(5), 2001, pp. 777-786

Authors: Vlieghe, P Clerc, T Pannecouque, C Witvrouw, M De Clercq, E Salles, JP Kraus, JL
Citation: P. Vlieghe et al., New 3 '-azido-3 '-deoxythymidin-5 '-yl O-(4-hydroxyalkyl or -alkenyl or -alkylepoxide) carbonate prodrugs: Synthesis and anti-HIV evaluation, J MED CHEM, 44(18), 2001, pp. 3014-3021

Authors: Heinisch, G Matuszczak, B Spielmann, E Witvrouw, M Pannecouque, C De Clercq, E
Citation: G. Heinisch et al., Pyridazines 92. Synthesis of dialkyldipyridazinodiazepinones as potential HIV-1 reverse transcriptase inhibitors, J HETERO CH, 38(1), 2001, pp. 125-130

Authors: Chaouni-Benabdallah, A Galtier, C Allouchi, H Kherbeche, A Chavignon, O Teulade, JC Witvrouw, M Pannecouque, C Snoeck, R Andrei, G Balzarini, J De Clercq, E Fauvelle, F Enguehard, C Gueiffier, A
Citation: A. Chaouni-benabdallah et al., 3-benzamido, ureido and thioureidoimidazo[1,2-a]pyridine derivatives as potential antiviral agents, CHEM PHARM, 49(12), 2001, pp. 1631-1635

Authors: Varvaresou, A Iakovou, K Filippatos, E Souli, C Calogeropoulou, T Ioannidou, I Kourounakis, AP Pannecouque, C Witvrouw, M Padalko, E Neyts, J De Clercq, E Tsotinis, A
Citation: A. Varvaresou et al., Synthesis, antiretroviral and antioxidant evaluation of a series of new benzo[b]furan derivatives, ARZNEI-FOR, 51(2), 2001, pp. 156-162

Authors: Casimiro-Garcia, A De Clercq, E Pannecouque, C Witvrouw, M Stup, TL Turpin, JA Buckheit, RW Cushman, M
Citation: A. Casimiro-garcia et al., Synthesis and anti-HIV activity of cosalane analogues incorporating nitrogen in the linker chain, BIO MED CH, 8(1), 2000, pp. 191-200

Authors: Santhosh, KC De Clercq, E Pannecouque, C Witvrouw, M Loftus, TL Turpin, JA Buckheit, RW Cushman, M
Citation: Kc. Santhosh et al., Anti-HIV activity of a series of cosalane amino acid conjugates, BIOORG MED, 10(22), 2000, pp. 2505-2508

Authors: Paul, GC De Clercq, E Pannecouque, C Witvrouw, M Loftus, TL Turpin, JA Buckheit, RW Cushman, M
Citation: Gc. Paul et al., Identification of optimal anion spacing for anti-HIV activity in a series of cosalane tetracarboxylates, BIOORG MED, 10(18), 2000, pp. 2149-2152

Authors: Peloponese, JM Gregoire, C Opi, S Esquieu, D Sturgis, J Lebrun, E Meurs, E Collette, Y Olive, D Aubertin, AM Witvrow, M Pannecouque, C De Clercq, E Bailly, C Lebreton, J Loret, EP
Citation: Jm. Peloponese et al., H-1-C-13 nuclear magnetic resonance assignment and structural characterization of HIV-1 Tat protein, CR AC S III, 323(10), 2000, pp. 883-894

Authors: Witvrouw, M Pannecouque, C Desmyter, J De Clercq, E Andries, K
Citation: M. Witvrouw et al., In vitro evaluation of the effect of temporary removal of HIV drug pressure, ANTIVIR RES, 46(3), 2000, pp. 215-221

Authors: Van Vaerenbergh, K Van Laethem, K Albert, J Boucher, CAB Clotet, B Floridia, M Gerstoft, J Hejdeman, B Nielsen, C Pannecouque, C Perrin, L Pirillo, MF Ruiz, L Schmit, JC Schneider, F Schoolmeester, A Schuurman, R Stellbrink, HJ Stuyver, L Van Lunzen, J Van Remoortel, B Van Wijngaerden, E Vella, S Witvrouw, M Yerly, S De Clercq, E Desmyter, J Vandamme, AM
Citation: K. Van Vaerenbergh et al., Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues, ANTIM AG CH, 44(8), 2000, pp. 2109-2117

Authors: Witvrouw, M Fikkert, V Pluymers, W Matthews, B Mardel, K Schols, D Raff, J Debyser, Z De Clercq, E Holan, G Pannecouque, C
Citation: M. Witvrouw et al., Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (Reverse transcriptase/integrase) in the virus replicative cycle, MOLEC PHARM, 58(5), 2000, pp. 1100-1108

Authors: Pluymers, W Neamati, N Pannecouque, C Fikkert, V Marchand, C Burke, TR Pommier, Y Schols, D De Clercq, E Debyser, Z Witvrouw, M
Citation: W. Pluymers et al., Viral entry as the primary target for the anti-HIV activity of chicoric acid and its tetra-acetyl esters, MOLEC PHARM, 58(3), 2000, pp. 641-648
Risultati: 1-25 | 26-38